Opaleye Management Inc. Q1 2021 Filing
Filed May 18, 2021
Portfolio Value
$680.8M
Holdings
58
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (58 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OCULOCULAR THERAPEUTIX INC | 6,480,000 | $106.3M | 15.62% | |
| 2 | CMRXEURCHIMERIX INC | 4,490,000 | $43.3M | 6.36% | |
| 3 | TARAPROTARA THERAPEUTICS INC | 2,558,472 | $40.3M | 5.92% | |
| 4 | BBIOBRIDGEBIO PHARMA INC | 583,767 | $36.0M | 5.28% | |
| 5 | CDXSCODEXIS INC | 1,400,000 | $32.0M | 4.71% | |
| 6 | ETONETON PHARMACEUTICALS INC | 4,040,000 | $29.6M | 4.34% | |
| 7 | MGNXMACROGENICS INC | 666,200 | $21.2M | 3.12% | |
| 8 | TCONTRACON PHARMACEUTICALS INC | 2,518,371 | $20.7M | 3.04% | |
| 9 | HROWHARROW HEALTH INC | 3,065,416 | $20.7M | 3.04% | |
| 10 | TCE2CELLDEX THERAPEUTICS INC | 985,000 | $20.3M | 2.98% | |
| 11 | XOMAXOMA CORP DEL | 437,500 | $17.9M | 2.62% | |
| 12 | RJR1STEREOTAXIS INC | 2,526,500 | $17.0M | 2.49% | |
| 13 | —NEOLEUKIN THERAPEUTICS INC | 1,225,000 | $15.1M | 2.22% | |
| 14 | —FORTRESS BIOTECH INC | 3,875,000 | $13.7M | 2.01% | |
| 15 | CYTKCYTOKINETICS INC | 580,000 | $13.5M | 1.98% | |
| 16 | AUTLAUTOLUS THERAPEUTICS PLC | 2,112,918 | $12.1M | 1.78% | |
| 17 | —GEMINI THERAPEUTICS INC | 810,500 | $11.0M | 1.61% | |
| 18 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 222,000 | $10.0M | 1.46% | |
| 19 | MCRB1EURSERES THERAPEUTICS | 300,000 | $9.8M | 1.44% | |
| 20 | KROSKEROS THERAPEUTICS INC | 157,500 | $9.7M | 1.42% | |
| 21 | —CHECKPOINT THERAPEUTICS INC | 2,925,963 | $9.2M | 1.35% | |
| 22 | PRQRPROQR THERAPEUTICS NV | 1,303,000 | $8.6M | 1.27% | |
| 23 | EPIEURESSA PHARMA INC | 284,050 | $8.3M | 1.21% | |
| 24 | AFIBACUTUS MEDICAL INC | 614,990 | $8.2M | 1.21% | |
| 25 | —ADAMAS PHARMACEUTICALS INC | 1,670,600 | $8.0M | 1.18% | |
| 26 | —CERECOR INC | 2,600,000 | $7.9M | 1.15% | |
| 27 | STROSUTRO BIOPHARMA INC | 341,950 | $7.8M | 1.14% | |
| 28 | PTGXPROTAGONIST THERAPEUTICS INC | 297,000 | $7.7M | 1.13% | |
| 29 | IMVTIMMUNOVANT INC | 467,000 | $7.5M | 1.10% | |
| 30 | PCVXVAXCYTE INC | 357,800 | $7.1M | 1.04% | |
| 31 | SMTISANARA MEDTECH INC | 225,000 | $7.0M | 1.03% | |
| 32 | GYRECATALYST BIOSCIENCES INC | 1,250,000 | $6.3M | 0.93% | |
| 33 | 0HJQAVEO BIOSCIENCES INC | 835,000 | $6.1M | 0.90% | |
| 34 | KNSAKINIKSA PHARMACEUTICALS LTD | 320,926 | $5.9M | 0.87% | |
| 35 | VSTMVERASTEM INC | 2,325,000 | $5.7M | 0.84% | |
| 36 | TELATELA BIO INC | 365,000 | $5.4M | 0.80% | |
| 37 | MEIPUSDMEI PHARMA INC | 1,556,000 | $5.3M | 0.78% | |
| 38 | CRDFCARDIFF ONCOLOGY INC | 576,000 | $5.3M | 0.78% | |
| 39 | AXONEURSIO GENE THERAPIES INC | 2,000,000 | $5.2M | 0.77% | |
| 40 | —APTOSE BIOSCIENCES INC | 871,800 | $5.2M | 0.77% | |
| 41 | —MYOVANT SCIENCES LTD | 249,800 | $5.1M | 0.76% | |
| 42 | FGENEURFIBROGEN INC | 147,000 | $5.1M | 0.75% | |
| 43 | 4NX1LUMOS PHARMA INC | 376,900 | $4.4M | 0.65% | |
| 44 | KZRKEZAR LIFE SCIENCES INC | 711,200 | $4.2M | 0.62% | |
| 45 | —OPTINOSE INC | 826,000 | $3.0M | 0.45% | |
| 46 | —HIGHCAPE CAPITAL ACQUISITION CORP | 241,300 | $2.9M | 0.42% | |
| 47 | CRNXCRINETICS PHARMACEUTICALS INC | 188,000 | $2.9M | 0.42% | |
| 48 | EDAEDAP TMS SA | 341,300 | $2.9M | 0.42% | |
| 49 | —SIERRA ONCOLOGY INC | 151,139 | $2.6M | 0.38% | |
| 50 | —BIOHAVEN PHARMACEUTICAL HLDG | 25,000 | $1.7M | 0.25% | |
| 51 | NVLSEURALPINE IMMUNE SCIENCES INC | 156,500 | $1.7M | 0.24% | |
| 52 | —AERPIO PHARMACEUTICALS INC | 1,000,000 | $1.3M | 0.19% | |
| 53 | —AYALA PHARMECEUTICALS INC | 108,551 | $1.2M | 0.17% | |
| 54 | CFRXUSDCONTRAFECT CORP | 244,000 | $1.2M | 0.17% | |
| 55 | —MAGENTA THERAPEUTICS INC | 88,400 | $1.0M | 0.15% | |
| 56 | RYIVIRACTA THERAPEUTICS INC | 103,600 | $958K | 0.14% | |
| 57 | LPTXEURLEAP THERAPEUTICS INC | 388,100 | $737K | 0.11% | |
| 58 | —BIOLINERX LTD | 16,667 | $47K | 0.01% |